Granules shares gain over 5% on U.S. FDA nod for ADHD generic capsules
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
STAT2d
Kids with ADHD and the Adderall shortage
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...
Pharmabiz16h
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...
FDA approves Qelbree label update for ADHD treatment
ROCKVILLE, Md. - Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company specializing in CNS diseases with an impressive 89% gross profit margin, has announced the FDA approval of a ...
Adderall shortage sparks scramble for ADHD medication alternatives
Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder to other forms of ...
Daily18h
Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate
Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...
RIPR: The Public's Radio8d
Adults with ADHD live shorter lives than those without a diagnosis, a new study finds
For example, people with ADHD might forget to take medications for diabetes or to make follow-up appointments with their ...
Adderall shortage linked to shift in ADHD treatment for children
A national shortage in a common treatment for attention-deficit hyperactivity disorder was associated with changes in stimulant prescriptions filled for children over recent years, a new study ...